H.R. 1730: Speeding Therapy Access Today Act of 2021

117th Congress · introduced 2021-03-10 · Health · Latest: Referred to the Subcommittee on Health.

federal

Follow this bill, step by step

Where it came from: introduced 2021-03-10 · official record
Who proposed it: Rep. Bilirakis, Gus M. [R-FL-12] · what a sponsor is
What happened next: no floor votes in our records yet. Why?
Where it stands now: Referred to the Subcommittee on Health. Not final yet: this can still change. We check for updates every day.
If it becomes law and spends money: follow the money to money laws, then agencies and contracts and grants.

What does this mean?

Official title

Speeding Therapy Access Today Act of 2021

Plain summary

Speeding Therapy Access Today Act of 2021 This bill requires and authorizes various actions to accelerate the development of therapies for rare diseases. The Food and Drug Administration (FDA) shall establish the Intercenter Institute on Rare Diseases and Conditions. The institute shall (1) coordinate engagement with relevant stakeholders, (2) build the FDA's expertise in the review of medical products to treat rare diseases, (3) coordinate regulatory science initiatives related to rare diseases, (4) establish and implement a program to make recommendations to address challenges associated with developing medical products to treat rare diseases in an individual or in very small populations, (5) convene a stakeholder meeting to consider potential amendments to labels for medical products to treat rare diseases, and (6) establish and carry out a program to facilitate voluntary communication between the sponsors of such medical products and third-party payers (e.g., insurance companies). The bill also authorizes the FDA to make grants to assist in developing practices related to the development and production of individualized therapies or therapies to treat very small populations. The bill also establishes an advisory committee to advise the FDA on issues related to the development of therapies to treat rare diseases.

Congressional Research Service summary (Introduced in House), quoted unchanged (nonpartisan). Read the source.

What a vote does

A “Yea” vote

If it passes both chambers and is signed, it becomes law.

A “Nay” vote

If it is not passed, current law stays as it is.

PSI Sci description of the legislative step (not an opinion).

What does this mean? (plain words)

Official text

Speeding Therapy Access Today Act of 2021

Source: Congressional Research Service summary (Introduced in House)

AI explanation – may be wrong, check the official text

No AI explanation yet. It takes up to a minute to write and is then saved for everyone.

Limited to a few requests an hour per person.

The strongest published arguments

Arguments for (supporters)

Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.

Arguments against (opponents)

Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.

Alternatives

Needs sources: no published alternatives yet (for example a different bill, a law instead of an amendment, or keeping current law). We only show items backed by a published source. Suggest one.

How did my representative vote? · This bill's floor votes

Officials and money

Sponsor: Rep. Bilirakis, Gus M. [R-FL-12] · 40 cosponsors

Cost estimate: No cost estimate published yet.

Cosponsors on this site

Darren Soto (D-FL), Jefferson Van Drew (R-NJ), Mike Levin (D-CA), John Joyce (R-PA), Claudia Tenney (R-NY), Susie Lee (D-NV), Brian K. Fitzpatrick (R-PA), Tom Cole (R-OK), Eleanor Holmes Norton (D-DC), Mike Kelly (R-PA), Deborah K. Ross (D-NC), David Kustoff (R-TN), Josh Gottheimer (D-NJ), Jared Huffman (D-CA), Mark DeSaulnier (D-CA), Stephen F. Lynch (D-MA), Joe Neguse (D-CO), Madeleine Dean (D-PA), Sanford D. Bishop, Jr. (D-GA), Melanie A. Stansbury (D-NM), Joe Wilson (R-SC), Jason Crow (D-CO), J. French Hill (R-AR), Doris O. Matsui (D-CA), Don Bacon (R-NE)

Sponsor's campaign money: Rep. Bilirakis, Gus M. [R-FL-12] reported raising $2.3 million (2025–2026). Details. Shown for context only; it does not mean any donor supported this bill.

No linked floor roll calls in our collected records yet. This does not mean the bill has never had a vote. Check the official bill history.

Words on this page, explained (2)

Ballot initiative: A proposed law or constitutional amendment that citizens place on the ballot by gathering enough voter signatures, so voters decide it directly. About half the states allow some form of it.
Bill: A proposed law. It becomes law only if it passes the legislature and is signed by the president or governor (or a veto is overridden).

Plain meanings written from linked sources. All words.

Sources

Congressional Research Service summary (Introduced in House)
Congress.gov
Data: GovInfo BILLSTATUS bulk data (Library of Congress), BILLSTATUS-117hr1730.xml <https://www.govinfo.gov/bulkdata/BILLSTATUS/117/hr>

Record fed-us-cong117-hr1730 · catalog fed-us-congress-bills-cong117 · updated 2026-11-15 by psicol fed-bills-cong117